Fig. 1From: Nanomedicine for increasing the oral bioavailability of cancer treatmentsSource: www.fda.govFDA-approved therapeutics in 2018–2020. The graph shows the fraction of approved therapeutics designed for oral delivery (red) compared to therapeutics developed for other administration routes (blue).Back to article page